• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Valeant's Tender Offer For Allergan - Just 4% Of Shares Tendered In Dismal Failure

Re: Valeant's Tender Offer For Allergan - Just 4% Of Shares Tendered In Dismal Failur

A chief level leadership group usually protects a company after an offer is on the table. A chief level leader doesn't let an activist hedge fund owner buy 10% of a 49B company. Wake up fools, they aren't going anywhere... They scoff at BS rumors - these guys are pros at getting this stuff done, something's gonna give, and so far I haven't been impressed with the team defense. Many people were let go, many more are scared, and the same fools keep singing praise for the leaders, I am just not buying it!
 




Re: Valeant's Tender Offer For Allergan - Just 4% Of Shares Tendered In Dismal Failur

A chief level leadership group usually protects a company after an offer is on the table. A chief level leader doesn't let an activist hedge fund owner buy 10% of a 49B company. Wake up fools, they aren't going anywhere... They scoff at BS rumors - these guys are pros at getting this stuff done, something's gonna give, and so far I haven't been impressed with the team defense. Many people were let go, many more are scared, and the same fools keep singing praise for the leaders, I am just not buying it!

Annnnnd the intern is so sad